| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4da492073da12347757cdf821512a01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c87b1f7158bec499783fa1b27aad08c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97bd68cb0a98913a5940c708e7ce1679 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942b91adbe0051a4d648aac55fe7897c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b32f2699a477db58cbd66cea33e80adb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f517878d608fe9aad020fc40d321e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7bcf7d4c3791822add2c9073756bef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0b22017644399f8dbf1a2738773935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6c3a0c1cd05df179dfc0abe9f4ba149 |
| publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018360809-A1 |
| titleOfInvention |
Novel Dosing Regimens of Celgosivir For The Prevention of Dengue |
| abstract |
Methods of preventing a disease resulting from a dengue virus (DENV) infection in a human subject, comprising administering to the human subject a compound of Formula (I), or pharmaceutical composition comprising a compound of Formula (I); a compound of Formula (I) can be first administered to an asymptomatic human subject followed by subsequent doses administered at least once daily. The methods of the invention can be used to prevent a disease resulting from primary and secondary DENV 1-4 viral infections. |
| priorityDate |
2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |